BDFS Capital’s Colgate-Palmolive CL Stock Holding History

BDFS Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$676K	Sell	7,375 -258	-3%	-$22.6K	0.29%	63
2026 Q1	$651K	Buy	7,633 +240	+3%	+$21.4K	0.31%	59
2025 Q4	$584K	Buy	+7,393	New	+$580K	0.29%	61

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BDFS Capital's CL Position: Q2 2026 in Review

BDFS Capital reduced its Colgate-Palmolive (CL) stake by 3.4% in Q2 2026, selling an estimated $22.6K and leaving 7,375 shares worth $676K. The position accounts for 0.29% of the portfolio, ranked #63.

BDFS Capital first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,003 funds tracked by Wall St. Rank hold CL as of Q2 2026.

BDFS Capital held 7,375 shares of Colgate-Palmolive worth $676K as of Q2 2026.
BDFS Capital sold 258 Colgate-Palmolive shares in Q2 2026, an estimated $22.6K.
Colgate-Palmolive made up 0.29% of BDFS Capital's portfolio in Q2 2026, its #63 holding.
BDFS Capital first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,003 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on BDFS Capital's 13F filing for Q2 2026, filed 15 Jul 2026.